Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Participate in Research
  3. Immune System

Immune System

Recruiting

Investigating treatment for patients with chronic graft-versus-host disease

The purpose of this study is to evaluate the safety, tolerability and preliminary activity of axatilimab in combination with ruxolitinib and to assess the contribution of axatilimab to the combination treatment effect in participants with chronic graft-versus-host disease.

Status
Recruiting
Principal Investigator
Jennifer White
Body Locations and Systems
Blood, Heart and Circulation
Immune System
Age
12 and above

Investigating the safety of frexalimab in adults with relapsing MS

The purpose of this study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of teriflunomide in male and female participants with relapsing forms of multiple sclerosis who are 18 to 55 years of age at the time of enrollment. 

Status
Recruiting
Principal Investigator
Alice Schabas
Body Locations and Systems
Brain and Nerves
Multiple Sclerosis
Immune System
Age
18-55

Collecting data for the Pacific Parkinson’s Research Centre Biobank

The purpose of this study is to collect biospecimens (fecal, urine, blood) and clinical data to serve as a resource for future research on Parkinson’s disease and other movement disorders. The careful collection, storage and retrieval of biospecimens and medical information for research projects are critical for improving understanding of healthy development and disease mechanisms and the subsequent development of effective treatments. Biospecimens from this biobank will be made available for ethically-approved studies.

Status
Recruiting
Principal Investigator
Silke Appel-Cresswell
Body Locations and Systems
Blood, Heart and Circulation
Brain and Nerves
Parkinson's Disease
Digestive System
Immune System
Kidneys and Urinary System
Mouth and Teeth
Age
19 and above

Testing the safety of an RSV vaccine in lung or kidney transplant recipients

The purpose of this study is to evaluate the immune response and safety of a new vaccine in preventing diseases due to infection with respiratory syncytial virus (RSV). This RSV vaccine will be tested in older adults who are recipients of lung or kidney transplants and are at an increased risk of RSV compared to healthy older adults. 

Status
Recruiting
Principal Investigator
Céline Bergeron
Body Locations and Systems
Immune System
Lungs and Breathing
Age
50 and above

Investigating the efficacy and safety of brepocitinib in adults with dermatomyositis

The purpose of this study is to assess the efficacy of two dose levels of brepocitinib in adults with dermatomyositis compared to a placebo. After 52 weeks of double-blind treatment, participants have the option to continue therapy in a 52-week, open-label extension phase where all participants will receive brepocitinib.

Status
Recruiting
Body Locations and Systems
Bones, Joints and Muscles
Immune System
Skin, Hair and Nails
Age
18-75

Assessing an immunomodulator in reducing respiratory tract infection morbidity in older adults

The purpose of this study is to test the ability of a new immune modulator, QBKPN, to boost natural immunity to improve health, including reducing respiratory infections. It will also measure the effect of QBKPN on non-respiratory infections, quality of life and overall survival.

Status
Recruiting
Principal Investigator
Theodore Steiner
Body Locations and Systems
Immune System
Lungs and Breathing
Age
65 and above

Characterizing immune response to kidney transplantation

The purpose of this study is to characterize a recipient's immune system response to kidney transplantation to uncover an immune signature of early graft rejection.

Status
Recruiting
Principal Investigator
Paul Keown
Body Locations and Systems
Immune System
Kidneys and Urinary System

Improving antigen matching for renal transplant patients

The purpose of this study is to establish a protocol for improved human leukocyte antigen (HLA) matching for renal transplant patients.

Status
Recruiting
Principal Investigator
Paul Keown
Body Locations and Systems
Immune System
Kidneys and Urinary System
Age
18 and above

Evaluating itolizumab to treat chronic graft-versus-host disease

The purpose of the study is to investigate the safety and efficacy of itolizumab versus placebo in individuals with acute graft-versus-host disease, when combined with corticosteroids as a first line treatment.

Status
Recruiting
Principal Investigator
Jennifer White
Body Locations and Systems
Immune System
Age
12 and above

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

The purpose of this study is evaluate the safety and efficacy of a new vaccine to protect children against bacteria that can lead to pneumococcal disease. 

Status
Recruiting
Principal Investigator
Manish Sadarangani
Body Locations and Systems
Immunizations
Area
Vancouver
Age
2 months

Countermeasures for COVID-19 Pandemic

The purpose of the study is to identify immune cells and antibodies that fight the novel coronavirus (SARS-CoV-2) from individuals who have been infected and recovered from COVID-19. Neutralizing antibodies will be used for the development of new therapies and diagnostic tools for COVID-19

Status
Recruiting
Principal Investigator
Theodore Steiner
Body Locations and Systems
Immune System and Disorders
Area
Vancouver
Age
18 and above

Multiple Sclerosis, Genes, Microbes, and Medication

The purpose of the main study is to investigate adverse drug reactions from multiple sclerosis (MS) disease modifying drugs by understanding the genetic factors that contribute to their cause. 

The sub-study investigates how the MS disease modifying drugs affect microbes in the gut and how human DNA affects the changes in the gut microbes following drug treatment. We are also interested in how gut microbes might relate to progressive MS.

recruitment poster

Status
Recruiting
Principal Investigator
Helen Tremlett
Body Locations and Systems
Multiple Sclerosis
Immune System
Area
Vancouver
Age
18 and above

Closed for Recruitment

Arthritis Health Journal Proof of Concept Study (AHJ)

The purpose of this study is to determine whether an online patient passport tool called the Arthritis Health Journal can assist people with rheumatoid arthritis in managing their disease.

Status
Closed for Recruitment
Principal Investigator
Diane Lacaille
Body Locations and Systems
Rheumatoid Arthritis
Area
Vancouver
Age
18 and above

Evaluating axatilimab to treat chronic graft-versus-host disease

The purpose of this study is to evaluate the efficacy, safety and tolerability of axatilimab at three different dose levels in participants with recurrent or refractory active chronic graft versus host disease (cGVHD) who have received at least two prior lines of systemic therapy.

Status
Closed for Recruitment
Principal Investigator
Jennifer White
Body Locations and Systems
Immune System
Age
2 and above

KidCove Study

The purpose of this study is to evaluate an investigational vaccine that may protect children between 6 months and 11 years old from getting sick if they come into contact with SARS-CoV-2, the virus that causes COVID-19.

Status
Closed for Recruitment
Principal Investigator
Manish Sadarangani
Body Locations and Systems
Immune System
Area
Vancouver
Age
6 months - 11 years

Inhaled Ciclesonide for Outpatients With COVID-19 (CONTAIN)

The purpose of this study is to examine the safety and efficacy of a steriod called ciclesonide in treating mild covid-19 disease. 

Status
Closed for Recruitment
Principal Investigator
Sara Belga
Body Locations and Systems
Immune System
Area
Vancouver
Age
18 and above

Examining the chronic burden of neuropsychiatric illness in COVID-19 patients

The purpose of this study is to explore certain aspects of the blood and brain to determine how a person may recover from COVID-19. In addition, this study will examine how the different aspects of COVID-19 may affect how a person thinks or feels. 

Status
Closed for Recruitment
Principal Investigator
William Panenka
Body Locations and Systems
Brain and Nerves
Immune System
Lungs and Breathing
Age
14-90

A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) (ZUMA-1)

This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-C19, an autologous anti-CD19 chimeric antigen receptor (CAR)-positive T cell therapy, in refractory aggressive Non-Hodgkin Lymphoma (NHL).

Status
Closed for Recruitment
Principal Investigator
Kevin Song
Body Locations and Systems
Immune System and Disorders
Area
Vancouver
Age
18 and above

Determinants of late initiation and treatment interruption in a context of expansion of highly active antiretroviral therapy (HAART) in British Columbia, Canada

To identify the clinical, social and cultural determinants of late HAART initiation and to determine the impact of HIV-related care (routine access to care, physician experience, physical and social barriers to care) and use of community-based organizations on HAART uptake and retention.

Status
Closed for Recruitment
Body Locations and Systems
HIV
Area
Vancouver
Age
19 and above

Employment and Arthritis: Making it Work (MIW)

The investigators plan to conduct a randomized controlled trial to evaluate the effectiveness and the cost effectiveness of an on-line eLearning program (entitled Employment and Arthritis: Making it Work) designed to help people with inflammatory arthritis stay employed. The program also includes assessments with 1) an occupational therapist, and 2) a vocational rehabilitation counsellor at the end of the program to help participants identify and obtain necessary changes at work. People from three provinces will be recruited from collaborators' patient and program recipient lists.

Status
Closed for Recruitment
Principal Investigator
Diane Lacaille
Body Locations and Systems
Psoriatic Arthritis
Rheumatoid Arthritis
Lupus
Ankylosing Spondylitis
Area
Richmond
Age
18-59
Subscribe to Immune System

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy